Literature DB >> 11852098

Frataxin knockin mouse.

Carlos J Miranda1, Manuela M Santos, Keiichi Ohshima, Julie Smith, Liangtao Li, Michaeline Bunting, Mireille Cossée, Michael Koenig, Jorge Sequeiros, Jerry Kaplan, Massimo Pandolfo.   

Abstract

Friedreich ataxia is the consequence of frataxin deficiency, most often caused by a GAA repeat expansion in intron 1 of the corresponding gene. Frataxin is a mitochondrial protein involved in iron homeostasis. As an attempt to generate a mouse model of the disease, we introduced a (GAA)(230) repeat within the mouse frataxin gene by homologous recombination. GAA repeat knockin mice were crossed with frataxin knockout mice to obtain double heterozygous mice expressing 25-36% of wild-type frataxin levels. These mice were viable and did not develop anomalies of motor coordination, iron metabolism or response to iron loading. Repeats were meiotically and mitotically stable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852098     DOI: 10.1016/s0014-5793(02)02251-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  72 in total

Review 1.  Neurogenetics: single gene disorders.

Authors:  S-M Pulst
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 2.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

3.  Expanded GAA repeats impede transcription elongation through the FXN gene and induce transcriptional silencing that is restricted to the FXN locus.

Authors:  Yanjie Li; Yue Lu; Urszula Polak; Kevin Lin; Jianjun Shen; Jennifer Farmer; Lauren Seyer; Angela D Bhalla; Natalia Rozwadowska; David R Lynch; Jill Sergesketter Butler; Marek Napierala
Journal:  Hum Mol Genet       Date:  2015-09-23       Impact factor: 6.150

Review 4.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

5.  Association between trinucleotide CAG repeats of the DNA polymerase gene (POLG) with age of onset of Iranian Friedreich's ataxia patients.

Authors:  Mohammad Mehdi Heidari; Massoud Houshmand; Saman Hosseinkhani; Shahriar Nafissi; Barbara Scheiber-Mojdehkar; Mehri Khatami
Journal:  Neurol Sci       Date:  2008-11-28       Impact factor: 3.307

6.  Rapid and Complete Reversal of Sensory Ataxia by Gene Therapy in a Novel Model of Friedreich Ataxia.

Authors:  Françoise Piguet; Charline de Montigny; Nadège Vaucamps; Laurence Reutenauer; Aurélie Eisenmann; Hélène Puccio
Journal:  Mol Ther       Date:  2018-05-28       Impact factor: 11.454

7.  Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability.

Authors:  Sherman Ku; Elisabetta Soragni; Erica Campau; Elizabeth A Thomas; Gulsah Altun; Louise C Laurent; Jeanne F Loring; Marek Napierala; Joel M Gottesfeld
Journal:  Cell Stem Cell       Date:  2010-11-05       Impact factor: 24.633

8.  Neurobehavioral deficits in the KIKO mouse model of Friedreich's ataxia.

Authors:  Marissa Z McMackin; Chelsea K Henderson; Gino A Cortopassi
Journal:  Behav Brain Res       Date:  2016-08-26       Impact factor: 3.332

Review 9.  Small molecules affecting transcription in Friedreich ataxia.

Authors:  Joel M Gottesfeld
Journal:  Pharmacol Ther       Date:  2007-08-09       Impact factor: 12.310

Review 10.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.